The Dose-Effect Relationship of Pravastatin to Vascular Endothelial Function of CHD Patients

胡伟,陆国平,沈卫峰
DOI: https://doi.org/10.3969/j.issn.1673-6583.2002.01.019
2002-01-01
Abstract:Objective: To explore the effects and dose-effect relationship of various doses of pravastatin including 10mg, 20mg and 40mg/day to vascular endothelial function. Methods: There are 48 male CHD patients diagnosed by coronary artery angiography in our study. They were randomly divided into four groups: including control group who don't use pravastatin and three pravastatin groups (10mg/day、10mg/ day、40mg/day), each group has 12 patients. We examined endothelium-dependent flux modulated dilation of brachial ratery by using Ultrasound. Moreover, we also record serum levels of lipids at the beginning and the end of this study. Results: After six weeks treatment, three pravastatin groups (10mg, 20mg, 40mg) apparently reduced serum level of TC (10. 96% , 16. 59% , 24. 41% ; respectively) and serum level of LDL-C (17.19% , 26.02% , 40.19; respectively), All the value of P is less than 0.05. All three pravastatin groups could better the brachial endothelial function and it didn't relate to the serum levels of TC and LDL-C. The value of FMD of three pravastatin prousp increased 3.81% , 4.26% and 5.44% ; respectively (P0.05), but there was no statistic difference among them. Although the value of FMD increased incontrol group, it had no statistic significance. Conclusions: Various doses of pravastatin may apparently better the vascular endothe-lial function of CHD patients in six weeks, But it has no dose-effect relationship. and it doesn' t relate to serum levels of TC and LDL-C.
What problem does this paper attempt to address?